Tag: Drug discovery

Hewlett Packard Enterprise to build TSUBAME4.0 supercomputer for Tokyo Tech

businessnewstoday- May 20, 2023

Hewlett Packard Enterprise (HPE) has been chosen to construct the TSUBAME4.0 by the Tokyo Institute of Technology (Tokyo Tech) Global Scientific Information and Computing Center ... Read More

BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery

Raghuram Kadari- January 11, 2023

German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More

Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline

- February 16, 2022

Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million, in a move to considerably expand its ... Read More

Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition

- May 4, 2021

Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma ... Read More

Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership

- March 23, 2021

AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing ... Read More

Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities

- February 26, 2021

Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss ... Read More

PostEra, Pfizer partner to advance machine learning for drug discovery

pharmanewsdaily- December 7, 2020

PostEra, a biotech company specializing in machine learning solutions for preclinical drug discovery, has forged a partnership with Pfizer for speeding up the discovery of ... Read More

PharmaEngine, Sentinel Oncology partner to advance SOL-578 Chk1 inhibitor

pharmanewsdaily- December 6, 2020

PharmaEngine has signed a collaboration and license deal with UK-based Sentinel Oncology for advancing the new drug development of SOL-578, a checkpoint kinase 1 inhibitor ... Read More

PerkinElmer to acquire cell engineering company Horizon Discovery

pharmanewsdaily- November 3, 2020

US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to ... Read More

Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex

pharmanewsdaily- August 11, 2020

US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in ... Read More